Johnson & Johnson: Waiting For A Better Yield

Johnson & Johnson's dividend yield has gradually been getting less competitive relative to its peers.

While the company is still strong, competition in the pharmaceutical sector as well as litigation settlements are potential risk factors.

My yield target to invest further in this stock would be 3%.

At that yield, the stock would need to trade at $112 given the current dividend payout.

I am remaining long this stock, but don't intend on adding more shares for the moment.

READ FULL ARTICLE HERE